{"id":"NCT01698814","sponsor":"Alcon Research","briefTitle":"A Six-Week Safety Study of an Investigational Ophthalmic Solution","officialTitle":"A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AL-4943A Ophthalmic Solution Administered Once Daily","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2012-10-03","resultsPosted":"2014-02-28","lastUpdate":"2014-03-27"},"enrollment":518,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":null},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"AL-4943A Ophthalmic Solution","otherNames":[]},{"type":"DRUG","name":"AL-4943A Ophthalmic Solution Vehicle","otherNames":[]}],"arms":[{"label":"AL-4943A","type":"EXPERIMENTAL"},{"label":"AL-4943A Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to evaluate the ocular safety of an investigational ophthalmic solution in subjects 2 years of age and older with asymptomatic eyes when administered once daily in both eyes for up to 6 weeks.","primaryOutcome":{"measure":"Adverse Events","timeFrame":"An average of 6 weeks","effectByArm":[{"arm":"AL-4943A","deltaMin":0,"sd":null},{"arm":"AL-4943A Vehicle","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":14},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":330},"commonTop":[]}}